Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation

Summary

The goal of the present study is to evaluate if addition of methotrexate can restore remission after loss of response to infliximab after dose escalation. another goal is to evaluate if low dose methotrexate can maintain remission achieved by regular dose methotrexate by 6 months.

Timeline

Start

2015-07

Primary completion

2018-10-09

Completion

2018-10-09

Drugs

Indications